您的位置: 首页 > 农业专利 > 详情页

TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H
专利权人:
Alcafleu Management GmbH & Co. KG
发明人:
SACHSE Andreas,SACHSE Andreas,MARGOLIN David Harris,MARGOLIN David Harris
申请号:
SI200731746
公开号:
SI2066352T1
申请日:
2007.09.11
申请国别(地区):
SI
年份:
2016
代理人:
摘要:
A method for treatment of multiple sclerosis (MS) with Campath-1H with significant efficacy and a favourable safety profile is described, which offers an acceptable benefit/risk ratio. Especially described is the use of Campath-1H (alemtuzumab) for the production of a medicament for the treatment of multiple sclerosis (MS), comprising a first treatment cycle followed by at least one further treatment cycle of Campath-1H (alemtuzumab), in which each treatment cycle comprises 1-5 daily doses which are applied on consecutive days, wherein the daily dose is >0 and ‰¤ 12 mg, and wherein each treatment cycle is separated from the next cycle by at least 1 - 24 months. Also described are treatment regimens comprising the administration of less than 12 mg/day of Campath-1H for a period of 1-5 consecutive days.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充